C7ORF70 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.761200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.629600E-02
Normal-vs-Stage2
9.009200E-01
Normal-vs-Stage3
2.018600E-01
Normal-vs-Stage4
1.772400E-01
Stage1-vs-Stage2
1.691730E-02
Stage1-vs-Stage3
4.106800E-01
Stage1-vs-Stage4
7.042000E-02
Stage2-vs-Stage3
1.589240E-01
Stage2-vs-Stage4
6.628000E-02
Stage3-vs-Stage4
3.637900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.410400E-01
Normal-vs-AfricanAmerican
6.645000E-01
Normal-vs-Asian
9.375600E-01
Caucasian-vs-AfricanAmerican
8.910600E-01
Caucasian-vs-Asian
9.386200E-01
AfricanAmerican-vs-Asian
8.635400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.663200E-01
Normal-vs-Female
9.969800E-01
Male-vs-Female
2.809000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.167400E-01
Normal-vs-Age(41-60Yrs)
5.986200E-01
Normal-vs-Age(61-80Yrs)
6.672000E-01
Normal-vs-Age(81-100Yrs)
7.333400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.975600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.836400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.478600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.298260E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.272300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.215000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.661000E-01
Normal-vs-Daily Drinker
3.907000E-01
Normal-vs-Weekly Drinker
9.679000E-01
Normal-vs-Occasional Drinker
5.934200E-01
Normal-vs-Social Drinker
7.697400E-01
Non Drinker-vs-Daily Drinker
9.345600E-01
Non Drinker-vs-Weekly Drinker
3.012400E-01
Non Drinker-vs-Occasional Drinker
6.302900E-03
Non Drinker-vs-Social Drinker
3.332400E-02
Daily Drinker-vs-Weekly Drinker
3.333000E-01
Daily Drinker-vs-Occasional Drinker
1.297630E-02
Daily Drinker-vs-Social Drinker
5.371500E-02
Weekly Drinker-vs-Occasional Drinker
3.995600E-01
Weekly Drinker-vs-Social Drinker
6.283400E-01
Occasional Drinker-vs-Social Drinker
7.070200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.761200E-01
Normal-vs-Grade 2
9.018800E-01
Normal-vs-Grade 3
9.522200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.910400E-01
Grade 1-vs-Grade 3
1.502990E-01
Grade 1-vs-Grade 4
8.761200E-01
Grade 2-vs-Grade 3
1.412840E-01
Grade 2-vs-Grade 4
9.018800E-01
Grade 3-vs-Grade 4
9.522200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.937400E-01
Normal-vs-NonDiabetic
9.321000E-01
Diabetic-vs-NonDiabetic
1.654980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.864400E-01
Normal-vs-NoPancreatitis
8.818000E-01
Pancreatitis-vs-NoPancreatitis
7.751200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.730000E-01
Normal-vs-N1
9.637400E-01
N0-vs-N1
2.459800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.946000E-01
Normal-vs-TP53-NonMutant
7.420600E-01
TP53-Mutant-vs-TP53-NonMutant
3.521200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
